Alexander Cox (A Cox)

Publication Activity (10 Years)

Years Active: 2020-2024
Publications (10 Years): 8

Top Topics

Metastatic Renal Cell Carcinoma

Transcription Factor

Electronic Health Record

Risk Assessment

Top Venues

Clinical & translational immunology

Anticancer research

This page only lists publications with an associated author ORCID identifier.

Publications

Johanna Eckrich, Joerg Ellinger, Alexander Cox, Johannes Stein, Manuel Ritter, Andrew Blaikie, Sebastian Kuhn, Christoph Raphael Buhr
Urology consultants versus large language models: Potentials and hazards for medical advice in urology. BJUI compass 5 (5) (2024)
Johanna Eckrich, Joerg Ellinger, Alexander Cox, Johannes Stein, Manuel Ritter, Andrew Blaikie, Sebastian Kuhn, Christoph Raphael Buhr
Urology consultants versus large language models: Potentials and hazards for medical advice in urology. BJUI compass 5 (5) (2024)
Benedikt Hoeh, Cristina Cano Garcia, Severine Banek, Niklas Klümper, Alexander Cox, Joerg Ellinger, Philipp Schmucker, Oliver Hahn, Angelika Mattigk, Friedemann Zengerling, Philippe Becker, Kati Erdmann, Bjoern Thorben Buerk, Luka Flegar, Johannes Huber, Charis Kalogirou, Philip Zeuschner
Early CRP kinetics to predict long-term efficacy of first-line immune-checkpoint inhibition combination therapies in metastatic renal cell carcinoma: an updated multicentre real-world experience applying different CRP kinetics definitions. Clinical & translational immunology 12 (10) (2023)
Marthe von Danwitz, Niklas Klümper, Marit Bernhardt, Alexander Cox, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger, Johannes Stein
Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers. Cancers 15 (6) (2023)
Marthe von Danwitz, Niklas Klümper, Marit Bernhardt, Alexander Cox, Philipp Krausewitz, Abdullah Alajati, Glen Kristiansen, Manuel Ritter, Joerg Ellinger, Johannes Stein
Identification of F-Box/SPRY Domain-Containing Protein 1 (FBXO45) as a Prognostic Biomarker for TMPRSS2-ERG-Positive Primary Prostate Cancers. Cancers 15 (6) (2023)
Alexander Cox, Yuri Tolkach, Johannes Stein, Glen Kristiansen, Manuel Ritter, Jörg Ellinger
Otoferlin is a prognostic biomarker in patients with clear cell renal cell carcinoma: A systematic expression analysis. International journal of urology : official journal of the Japanese Urological Association 28 (4) (2021)
Alexander Cox, Chenming Zhao, Yuri Tolkach, Daniel Nettersheim, Doris Schmidt, Glen Kristiansen, Stefan C Mueller, Manuel Ritter, Stefan Hauser, Joerg Ellinger
Knockdown of Myoferlin Suppresses Migration and Invasion in Clear-Cell Renal-Cell Carcinoma. Anticancer research 40 (6) (2020)
Alexander Cox, Y Tolkach, G Kristiansen, M Ritter, J Ellinger
The lncRNA Fer1L4 is an adverse prognostic parameter in clear-cell renal-cell carcinoma. Clinical & translational oncology : official publication of the Federation of Spanish Oncology Societies and of the National Cancer Institute of Mexico 22 (9) (2020)